Veppanu leverages PROTAC-mediated ubiquitin–proteasome degradation to eliminate mutant estrogen receptor, aiming to bypass ESR1-driven endocrine resistance rather than merely inhibiting receptor ...

May 12 (Reuters) - Rigel Pharmaceuticals (RIGL.O), opens new tab said on Tuesday it has struck a global licensing deal for Arvinas (ARVN.O), opens new tab and Pfizer's (PFE.N), opens new tab recently ...

Pfizer and Arvinas had already been scouting for a buyer for breast cancer med Veppanu months before its May 1 FDA approval. (SasinParaksa/iStock/Getty Images Plus ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The deal centered on Rigel’s RIPK1 inhibitor ocadusertib, with Lilly paying $125 million upfront and promising as much as $835 million more to develop the small molecule back in 2021. (iStock / Getty ...

Shares of Rigel Pharmaceuticals (RIGL) reached a four-month low on Wednesday after the company, with its Q4 2025 results, projected a revenue decline for 2026 driven by a sharp fall in its contract ...

Rigel Pharmaceuticals (RIGL Quick Quote RIGL - Free Report) came out with quarterly earnings of $1.14 per share, missing the Zacks Consensus Estimate of $1.33 per share. This compares to earnings of ...

Rigel Pharmaceuticals (NASDAQ:RIGL) is set to give its latest quarterly earnings report on Tuesday, 2026-03-03. Here's what investors need to know before the announcement. Analysts estimate that Rigel ...

Rigel Pharmaceuticals (RIGL Quick Quote RIGL - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

It has been seven years since my first Rigel Pharmaceuticals (RIGL) article, where I was bullish on TAVALISSE and the company's impressive pipeline. I was eyeing a potential buy early in 2019 as the ...

Don't miss 'The Curse of Rigel ' Expansion Launch Trailer for Wartales, an open-world turn-based strategy RPG developed by Shiro Games. Players will enforce the King's will to venture into the County ...